Literature DB >> 21288738

Genetic predisposition to autoimmunity--what have we learned?

Ekta Rai1, Edward K Wakeland.   

Abstract

Rapid advances in genetic technologies have led to the identification of more than 85 loci that contribute to susceptibility to autoimmune diseases. These susceptibility genes are distributed throughout the innate and adaptive immune systems, indicating that dysregulations in both immune systems participate in the development of autoimmunity. A significant subset of these susceptibility genes are shared between multiple autoimmune diseases. However, the dysregulation of specific pathways, such as the pathogen recognition receptors of the innate immune system and the TNF supergene family, are significantly involved in some autoimmune diseases. Although these findings dramatically increase the details available concerning the nature of genetic predisposition to autoimmunity, a mechanistic understanding of the processes involved has not been achieved. Future studies must focus on correlating phenotypes with specific genotypes to improve our understanding of the immune processes that are dysregulated during the development of autoimmunity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21288738     DOI: 10.1016/j.smim.2011.01.015

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  36 in total

1.  Dysregulation of immune homeostasis in autoimmune diseases.

Authors:  Vijay K Kuchroo; Pamela S Ohashi; R Balfour Sartor; Carola G Vinuesa
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 2.  Application of computational methods in genetic study of inflammatory bowel disease.

Authors:  Jin Li; Zhi Wei; Hakon Hakonarson
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

3.  Connective tissue diseases: Correlating genotypes with disease phenotypes in SLE.

Authors:  Edward K Wakeland
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 4.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Common genetic variants modulate pathogen-sensing responses in human dendritic cells.

Authors:  Mark N Lee; Chun Ye; Alexandra-Chloé Villani; Towfique Raj; Weibo Li; Thomas M Eisenhaure; Selina H Imboywa; Portia I Chipendo; F Ann Ran; Kamil Slowikowski; Lucas D Ward; Khadir Raddassi; Cristin McCabe; Michelle H Lee; Irene Y Frohlich; David A Hafler; Manolis Kellis; Soumya Raychaudhuri; Feng Zhang; Barbara E Stranger; Christophe O Benoist; Philip L De Jager; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2014-03-07       Impact factor: 47.728

6.  B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.

Authors:  Jun Sik Lee; Lisa Scandiuzzi; Anjana Ray; Joyce Wei; Kimberly A Hofmeyer; Yael M Abadi; P'ng Loke; Juan Lin; Jianda Yuan; David V Serreze; James P Allison; Xingxing Zang
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

7.  Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease.

Authors:  S Dionne; M R Calderon; J H White; B Memari; I Elimrani; B Adelson; C Piccirillo; E G Seidman
Journal:  Mucosal Immunol       Date:  2014-04-30       Impact factor: 7.313

Review 8.  Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases.

Authors:  Xu-Jie Zhou; Hong Zhang
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

9.  Sex chromosome aneuploidies among men with systemic lupus erythematosus.

Authors:  Skyler P Dillon; Biji T Kurien; Shibo Li; Gail R Bruner; Kenneth M Kaufman; John B Harley; Patrick M Gaffney; Daniel J Wallace; Michael H Weisman; R Hal Scofield
Journal:  J Autoimmun       Date:  2011-12-06       Impact factor: 7.094

Review 10.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.